AEGON LTD.'s income statement, balance sheet and cash flow statement as filed with the SEC (10-K and 10-Q), with the latest fiscal years and quarters. In its latest fiscal year (Dec 31, 2025 · FY), AEGON LTD. reported revenue of $3.7B (+7.6% year on year) and net income of $836.0M (+157.2% year on year).
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Insurance revenue | $9.1B | $9.8B | $10.4B | — |
| Insurance service expenses | ($9.4B) | ($9.8B) | ($10.2B) | — |
| Net income / (expenses) on reinsurance held | $836.0M | $325.0M | $182.0M | — |
| Insurance service result | $511.0M | $376.0M | $342.0M | — |
| Interest revenue on financial instruments calculated using the effective interest method | $2.7B | $3.3B | $3.3B | — |
| Interest income from instruments measured at FVPL | $615.0M | — | — | — |
| Other investment income | $1.2B | — | — | — |
| Results from financial transactions | $15.6B | $19.2B | $19.2B | ($35.1B) |
| Impairment (losses) / reversals | ($46.0M) | $229.0M | $90.0M | — |
| Insurance finance income / (expenses) | ($20.2B) | ($25.3B) | ($25.5B) | — |
| Net reinsurance finance income / (expenses) on reinsurance held | $564.0M | $611.0M | $699.0M | — |
| Interest expenses | ($135.0M) | — | — | — |
| Insurance net investment result | $1.2B | — | — | — |
| Interest revenue on financial instruments calculated using the effective interest method | $636.0M | — | — | — |
| Interest income from instruments measured at FVPL | $217.0M | — | — | — |
| Other investment income | $825.0M | — | — | — |
| Results from financial transactions | $10.1B | $1.0M | $0 | ($2.0M) |
| Impairment (losses) / reversals | ($22.0M) | — | — | — |
| Investment contract income / (expenses) | ($11.4B) | — | — | — |
| Interest expenses | ($18.0M) | — | — | — |
| Other net investment result | $331.0M | — | — | — |
| Interest charges | ($178.0M) | — | — | — |
| Financing net investment result | ($178.0M) | — | — | — |
| Total net investment result | $438.0M | $139.0M | — | — |
| Fees and commission income | $2.4B | $2.4B | $2.2B | $2.5B |
| Other operating expenses | ($2.9B) | ($3.0B) | ($3.0B) | — |
| Other income / (charges) | $130.0M | $145.0M | ($57.0M) | — |
| Other result | ($408.0M) | ($438.0M) | ($894.0M) | — |
| Result before share in profit / (loss) of joint ventures, associates and tax | $541.0M | $77.0M | ($691.0M) | ($1.8B) |
| Investment income | $46.0M | $2.1B | $1.8B | $5.6B |
| Total revenues | $3.7B | $3.4B | $3.5B | $21.3B |
| Total income | $88.0M | $87.0M | $108.0M | ($10.4B) |
| Commissions and expenses | $209.0M | $95.0M | $104.0M | $68.0M |
| Interest charges and related fees | $96.0M | $129.0M | $137.0M | $329.0M |
| Total charges | $305.0M | $224.0M | $241.0M | ($8.6B) |
| Result before tax from continuing operations | $1.0B | $660.0M | ($391.0M) | ($1.5B) |
| Income tax (expense) / benefit | ($65.0M) | $16.0M | $209.0M | $518.0M |
| Net result from continuing and discontinued operations | $980.0M | $676.0M | ($199.0M) | ($1.4B) |
| Net result group companies | $1.2B | $806.0M | ($65.0M) | ($1.3B) |
| Owners of Aegon Ltd. | $977.0M | $688.0M | ($179.0M) | ($1.4B) |
| Non-controlling interests | $3.0M | ($12.0M) | ($20.0M) | $29.0M |
| Share in profit / (loss) of joint ventures | $303.0M | $238.0M | $196.0M | $249.0M |
| Share in profit / (loss) of associates | $200.0M | $345.0M | $103.0M | ($11.0M) |
| Net result from continuing operations | $980.0M | $676.0M | ($182.0M) | ($1.0B) |
| Net result from discontinued operations | $0 | $0 | ($17.0M) | ($379.0M) |
| Line item | Jun 30, 2026 · YTD |
|---|---|
| Insurance revenue | $4.2B |
| Insurance service expenses | ($4.6B) |
| Net income / (expenses) on reinsurance held | $372.0M |
| Insurance service result | $54.0M |
| Interest revenue on financial instruments calculated using the effective interest method | $1.2B |
| Interest income from instruments measured at FVPL | $105.0M |
| Other investment income | $6.0M |
| Results from financial transactions | $5.3B |
| Impairment (losses) / reversals | $16.0M |
| Insurance finance income / (expenses) | ($6.7B) |
| Net reinsurance finance income / (expenses) on reinsurance held | $332.0M |
| Interest expenses | ($39.0M) |
| Insurance net investment result | ($29.0M) |
| Interest revenue on financial instruments calculated using the effective interest method | $311.0M |
| Interest income from instruments measured at FVPL | $40.0M |
| Other investment income | $2.0M |
| Results from financial transactions | $2.3B |
| Impairment (losses) / reversals | $0 |
| Investment contract income / (expenses) | ($2.5B) |
| Interest expenses | ($7.0M) |
| Other net investment result | $125.0M |
| Interest charges | ($92.0M) |
| Financing net investment result | ($92.0M) |
| Total net investment result | $346.0M |
| Fees and commission income | $1.0B |
| Other operating expenses | ($1.2B) |
| Other income / (charges) | $24.0M |
| Other result | ($165.0M) |
| Result before share in profit / (loss) of joint ventures, associates and tax | $235.0M |
| Share in profit / (loss) of joint ventures | $155.0M |
| Share in profit / (loss) of associates | $211.0M |
| Result before tax from continuing operations | $601.0M |
| Income tax (expense) / benefit | ($45.0M) |
| Net result from continuing operations | $556.0M |
| Net result from discontinued operations | $52.0M |
| Net result from continuing and discontinued operations | $608.0M |
| Owners of Aegon Ltd. | $614.0M |
| Non-controlling interests | ($6.0M) |
| Basic earnings per common share | $0.39 |
| Diluted earnings per common share | $0.39 |
| Basic earnings per common share from continuing operations | $0.35 |
| Diluted earnings per common share from continuing operations | $0.35 |
| Basic earnings per common share B | $0.01 |
| Diluted earnings per common share B | $0.01 |
| Basic earnings per common share B from continuing operations | $0.01 |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Cash and cash equivalents | $2.7B | $3.5B | $4.1B | $3.4B |
| Investments | $285.1B | $293.7B | $266.4B | $76.8B |
| Derivatives | $485.0M | $771.0M | $1.4B | $2.8B |
| Investments in joint ventures | $1.6B | $1.5B | $1.4B | $1.4B |
| Investments in associates | $2.6B | $3.1B | $2.9B | $165.0M |
| Reinsurance contract assets | $17.2B | $16.0B | $16.6B | — |
| Insurance contract assets | $18.0M | $125.0M | $185.0M | — |
| Defined benefit assets | $95.0M | $110.0M | $103.0M | $87.0M |
| Reimbursement rights | $28.0M | $9.0M | $20.0M | — |
| Deferred tax assets | $1.9B | $2.4B | $2.4B | $1.8B |
| Shares in group companies | 9.3B | 8.7B | 8.5B | 13.6B |
| Loans to group companies | $13.0M | $330.0M | $780.0M | $1.4B |
| Other non-current assets | $53.0M | $40.0M | $0 | $109.0M |
| Non-current assets | $7.3B | $8.6B | $7.3B | — |
| Receivables from group companies | $266.0M | $20.0M | $138.0M | $31.0M |
| Other receivables | $27.0M | $106.0M | $77.0M | $236.0M |
| Other current assets | $3.1B | $1.9B | $1.6B | $1.7B |
| Accrued interest and rent | $0 | $4.0M | $18.0M | $9.0M |
| Receivables | $302.0M | $162.0M | $281.0M | $398.0M |
| Deferred expenses | $452.0M | $490.0M | $447.0M | $12.9B |
| Other assets and receivables | $4.5B | $5.0B | $4.7B | $10.2B |
| Intangible assets | $519.0M | $575.0M | $504.0M | $1.2B |
| Total assets | $317.2B | $327.4B | $301.6B | $401.8B |
| Shareholders' Equity | $7.4B | $7.2B | $7.5B | $12.1B |
| Other equity instruments | $2.0B | $2.0B | $2.0B | $1.9B |
| Issued capital and reserves attributable to owners of Aegon Ltd. | $9.4B | $9.2B | $9.4B | $14.0B |
| Non-controlling interests | $85.0M | $126.0M | $129.0M | $176.0M |
| Subordinated borrowings | $1.5B | $1.7B | $2.2B | $2.3B |
| Trust pass-through securities | $99.0M | $113.0M | $111.0M | $118.0M |
| Reinsurance contract liabilities | $195.0M | $303.0M | $608.0M | — |
| Insurance contract liabilities | $176.1B | $188.4B | $177.4B | — |
| Investment contract liabilities with discretionary participation features | $21.3B | $22.3B | $21.6B | — |
| Investment contracts without discretionary participation features | $97.8B | — | — | $10.7B |
| Derivatives | $1.5B | $2.4B | $2.5B | $6.1B |
| Borrowings | $2.0B | $3.0B | $2.4B | $4.1B |
| Share capital | $229 | $241.0M | $265.0M | $319.0M |
| Share premium | $6.9B | $6.9B | $6.9B | — |
| Revaluation account | ($4.3B) | ($3.7B) | ($3.8B) | ($4.5B) |
| Legal reserves – foreign currency translation reserve | $49.0M | $999.0M | $474.0M | $1.0B |
| Legal reserves in respect of group companies | $1.2B | $1.4B | $1.1B | $2.4B |
| Retained earnings, including treasury shares | 1.6B | 1.8B | 3.7B | 8.9B |
| Remeasurement of defined benefit plans of group companies | ($966.0M) | ($1.1B) | ($1.0B) | ($1.6B) |
| Legal reserves revaluation account | $1.8B | — | — | — |
| Net result | $977.0M | $688.0M | ($179.0M) | ($1.4B) |
| Group equity | $9.5B | $9.3B | $9.6B | $14.2B |
| Line item | Jun 30, 2026 |
|---|---|
| Cash and cash equivalents | $3.5B |
| Assets held for sale | $138.2B |
| Investments | $167.2B |
| Derivatives | $681.0M |
| Investments in joint ventures | $1.7B |
| Investments in associates | $2.8B |
| Reinsurance contract assets | $17.4B |
| Insurance contract assets | $16.0M |
| Deferred tax assets | $1.9B |
| Deferred expenses | $457.0M |
| Other assets and receivables | $3.5B |
| Intangible assets | $387.0M |
| Total assets | $337.7B |
| Shareholders' Equity | $7.3B |
| Other equity instruments | $1.6B |
| Issued capital and reserves attributable to owners of Aegon Ltd. | $8.9B |
| Non-controlling interests | $72.0M |
| Group equity | $9.0B |
| Subordinated borrowings | $1.5B |
| Trust pass-through securities | $102.0M |
| Reinsurance contract liabilities | $201.0M |
| Insurance contract liabilities | $137.4B |
| Investment contract liabilities with discretionary participation features | $20.0M |
| Investment contracts without discretionary participation features | $41.8B |
| Derivatives | $1.3B |
| Borrowings | $2.2B |
| Liabilities held for sale | $137.1B |
| Other liabilities | $7.1B |
| Total liabilities | $328.7B |
| Total equity and liabilities | $337.7B |
| Line item | Dec 31, 2025 · FY | Dec 31, 2024 · FY | Dec 31, 2023 · FY | Dec 31, 2022 · FY |
|---|---|---|---|---|
| Result before tax from continuing operations | $1.0B | $660.0M | ($391.0M) | ($1.5B) |
| Result before tax from discontinued operations | $0 | $0 | $458.0M | $2.4B |
| Impairment loss on measurement of disposal group | $0 | $0 | ($413.0M) | ($1.8B) |
| Result before tax from continuing and discontinued operations | $1.0B | — | — | — |
| Results from financial transactions | ($26.2B) | ($20.7B) | ($20.5B) | $45.2B |
| Amortization and depreciation | ($167.0M) | ($31.0M) | ($163.0M) | $1.2B |
| Impairment losses | $69.0M | $237.0M | $116.0M | $49.0M |
| Results from (re)insurance contracts and investment contracts with discretionary participation features | $19.2B | — | — | — |
| Income from joint ventures | ($303.0M) | ($238.0M) | ($200.0M) | ($286.0M) |
| Income from associates | ($200.0M) | ($345.0M) | ($118.0M) | ($4.0M) |
| Release of cash flow hedging reserve | ($127.0M) | ($124.0M) | ($130.0M) | ($126.0M) |
| Other | $187.0M | $445.0M | $892.0M | $796.0M |
| Adjustments of non-cash items | ($7.6B) | ($5.2B) | ($2.5B) | $46.8B |
| Investment contracts without discretionary participation features | $13.8B | — | — | — |
| Accrued expenses and other liabilities | $95.0M | ($586.0M) | ($442.0M) | ($929.0M) |
| Accrued income and prepayments | ($156.0M) | ($71.0M) | $1.3B | ($1.5B) |
| Changes in accruals | $13.7B | $12.1B | $10.6B | ($57.6B) |
| Insurance contracts | ($11.3B) | ($11.9B) | ($11.8B) | — |
| Investment contracts with discretionary participation features | ($2.7B) | — | — | — |
| Reinsurance contracts held | ($1.7B) | $1.9B | $923.0M | — |
| Purchase of investments (other than money market investments) | ($65.1B) | ($48.5B) | ($43.4B) | ($22.6B) |
| Purchase of derivatives | $46.0M | ($64.0M) | ($1.0B) | ($4.1B) |
| Disposal of investments (other than money market investments) | $74.3B | $52.6B | $52.6B | $32.6B |
| Disposal of derivatives | ($188.0M) | ($107.0M) | ($1.6B) | ($2.5B) |
| Net change in cash collateral | ($8.0M) | ($1.3B) | $1.6B | ($3.2B) |
| Net purchase of money market investments | ($94.0M) | — | ($1.9B) | ($362.0M) |
| Cash flow movements on operating items not reflected in income | ($6.8B) | ($6.7B) | ($6.6B) | $13.4B |
| Tax (paid)/ received | $76.0M | ($80.0M) | ($321.0M) | ($37.0M) |
| Other | ($10.0M) | ($12.0M) | $4.0M | $1.2B |
| Net cash flows from operating activities | $434.0M | $762.0M | $864.0M | $2.9B |
| Purchase of intangible assets (other than future servicing rights) | ($13.0M) | ($15.0M) | ($51.0M) | ($26.0M) |
| Purchase of equipment and real estate for own use | ($41.0M) | ($51.0M) | ($65.0M) | ($72.0M) |
| Acquisition of subsidiaries, net of cash | ($13.0M) | ($41.0M) | ($34.0M) | ($146.0M) |
| Acquisition/capital contributions joint ventures and associates | ($82.0M) | ($8.0M) | ($253.0M) | ($73.0M) |
| Disposal of intangible asset | $0 | $0 | $3.0M | $0 |
| Disposal of equipment | $5.0M | $20.0M | $46.0M | $9.0M |
| Disposal of subsidiaries and businesses, net of cash | ($2.0M) | $19.0M | ($2.0B) | $604.0M |
| Disposal joint ventures and associates | $756.0M | $37.0M | $12.0M | $185.0M |
| Dividend received from joint ventures and associates | $400.0M | $340.0M | $310.0M | $137.0M |
| Other | $0 | ($1.0M) | $0 | ($1.0M) |
| Net cash flows from investing activities | $1.0B | $300.0M | ($2.0B) | $616.0M |
| Purchase of treasury shares | -549.0M | -925.0M | -1.1B | -597.0M |
| Proceeds from TRUPS, Subordinated borrowings and borrowings | $946.0M | $700.0M | $2.7B | $3.6B |
| Repayment of TRUPS 1, subordinated loans and borrowings | ($1.7B) | — | — | ($4.1B) |
| Dividends paid | ($596.0M) | ($521.0M) | ($494.0M) | ($167.0M) |
| Line item | Jun 30, 2026 · YTD |
|---|---|
| Result before tax from continuing operations | $601.0M |
| Result before tax from discontinued operations | $69.0M |
| Result before tax from continuing and discontinued operations | $670.0M |
| Results from financial transactions | ($17.2B) |
| Amortization and depreciation | ($58.0M) |
| Impairment losses | ($16.0M) |
| Results from (re)insurance contracts and investment contracts with discretionary participation features | $11.3B |
| Income from joint ventures | ($155.0M) |
| Income from associates | ($211.0M) |
| Release of cash flow hedging reserve | ($42.0M) |
| Other | $94.0M |
| Adjustments of non-cash items | ($6.3B) |
| Investment contracts without discretionary participation features | $9.1B |
| Accrued expenses and other liabilities | $258.0M |
| Accrued income and prepayments | ($20.0M) |
| Changes in accruals | $9.3B |
| Insurance contracts | ($6.0B) |
| Investment contracts with discretionary participation features | ($1.4B) |
| Reinsurance contracts held | $785.0M |
| Purchase of investments (other than money market investments) | ($28.7B) |
| Purchase of derivatives | ($27.0M) |
| Disposal of investments (other than money market investments) | $32.0B |
| Disposal of derivatives | $203.0M |
| Net change in cash collateral | ($143.0M) |
| Net purchase of money market investments | $821.0M |
| Cash flow movements on operating items not reflected in income | ($2.5B) |
| Tax (paid)/ received | ($19.0M) |
| Other | $2.0M |
| Net cash flows from operating activities | $1.2B |
| Purchase of intangible assets (other than future servicing rights) | ($7.0M) |
| Purchase of equipment and real estate for own use | ($20.0M) |
| Acquisition of subsidiaries, net of cash | $0 |
| Acquisition/capital contributions joint ventures and associates | ($4.0M) |
| Disposal of intangible asset | $0 |
| Disposal joint ventures and associates | $46.0M |
| Dividend received from joint ventures and associates | $201.0M |
| Net cash flows from investing activities | $217.0M |
| Purchase of treasury shares | -226.0M |
| Proceeds from TRUPS, Subordinated borrowings and borrowings | $981.0M |
| Repayment of TRUPS 1, subordinated loans and borrowings | ($781.0M) |
| Repayment of perpetuals securities | ($305.0M) |
| Coupons on perpetual securities | ($37.0M) |
| Payment of lease liabilities | ($13.0M) |
| Change in ownership non-controlling interests | ($9.0M) |
| Net cash flows from financing activities | ($391.0M) |
AEGON LTD. score and earnings-call analysis · All covered companies
Figures as reported in SEC filings. General information, not investment advice.